BioNTech SE's total assets for Q4 2023 were €23.01B, a decrease of -1.17% from the previous quarter. BNTX total liabilities were €2.76B for the fiscal quarter, a -14.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.